相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immediate and Sustained Improvements in Working Memory After Selective Stimulation of alpha 7 Nicotinic Acetylcholine Receptors
Stacy A. Castner et al.
BIOLOGICAL PSYCHIATRY (2011)
Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Theo Dinklo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Julie M. Miwa et al.
NEURON (2011)
ULTRA-LOW EXPOSURE TO ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS ELICITS AN IMPROVEMENT IN COGNITION THAT CORRESPONDS WITH AN INCREASE IN ALPHA-7 RECEPTOR EXPRESSION IN RODENTS: IMPLICATIONS FOR LOW DOSE CLINICAL EFFICACY
J. L. Werkheiser et al.
NEUROSCIENCE (2011)
Cognitive Improvement by Activation of alpha(7) Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Morten S. Thomsen et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimer's Disease
Simon N. Haydar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia
T. A. Hauser et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2H)-carboxamide)
John Dunlop et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Activation and Desensitization of Nicotinic α7-type Acetylcholine Receptors by Benzylidene Anabaseines and Nicotine
Roger L. Papke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A role for LYNX2 in anxiety-related behavior
Ayse B. Tekinay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha 7 nicotinic receptor agonist SSR180711
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2008)
RIC-3 and nicotinic acetylcholine receptors: Biogenesis, properties, and diversity
Millet Treinin
Biotechnology Journal (2008)
RIC-3: a nicotinic acetylcholine receptor chaperone
N. S. Millar
BRITISH JOURNAL OF PHARMACOLOGY (2008)
First administration of cytidine diphosphocholine and galantamine in schizophrenia: A sustained alpha(7) nicotinic agonist strategy
Stephen I. Deutsch et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Allosteric modulators of the α7 nicotinic acetylcholine receptor
Ramin Faghih et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Nicotinic acetylcholine receptors and modulation of learning in 4-and 27-month-old rabbits
Jian-Guo Li et al.
NEUROPSYCHOPHARMACOLOGY (2008)
An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo
Daniel B. Timmermann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Broad-spectrum efficacy across cognitive domains by α7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S. Bitner et al.
JOURNAL OF NEUROSCIENCE (2007)
Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes
Jens Halvard Gronlien et al.
MOLECULAR PHARMACOLOGY (2007)
Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators
Herman J. Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Jared W. Young et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Performance of α7 nicotinic receptor null mutants is impaired in appetitive learning measured in a signaled nose poke task
JJ Keller et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance
JJ Buccafusco et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor:: In vitro and in vivo characterization
RS Hurst et al.
JOURNAL OF NEUROSCIENCE (2005)
Changes in acetylcholine extracellular levels during cognitive processes
G Pepeu et al.
LEARNING & MEMORY (2004)
Antidepressant drug treatment induces Arc gene expression in the rat brain
Q Pei et al.
NEUROSCIENCE (2003)
Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas
JA Dani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
分享论文
